Affinage

SNX30

Sorting nexin-33 · UniProt Q8WV41

Length
574 aa
Mass
65.3 kDa
Annotated
2026-06-10
12 papers in source corpus 4 papers cited in narrative 4 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 3/4 claims corpus-supported (75%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

SNX30 is a sorting nexin family member that operates on endocytic membranes and engages in selective protein-protein interactions through its SH3 domain (PMID:16374509, PMID:32513819). It binds the metalloproteinase-disintegrin ADAM15 with nanomolar affinity, and this association is governed by alternative mRNA splicing of ADAM15: robust cellular binding occurs only for ADAM15 isoforms retaining the most carboxyterminal proline cluster, establishing splice-dependent control of the SNX30–ADAM15 interaction (PMID:16374509, PMID:19718658). SNX30 also forms heterodimers with SNX4 that localize to tubulovesicular endocytic membranes, distinguishing it from the SNX4–SNX7 heterodimer that mediates autophagy and ATG9A trafficking (PMID:32513819). In lung adenocarcinoma cells, SNX30 overexpression suppresses proliferation and drives ferroptosis—raising ROS and intracellular iron while depleting cysteine, glutathione, and GPX4—by acting upstream of and negatively regulating SETDB1, since restoring SETDB1 reverses the ferroptotic phenotype (PMID:39780196). The structural basis of these functions and the connection between SNX30's membrane-trafficking activity and its tumor-suppressive role have not been resolved in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2006 Medium

    Establishing whether SNX30 has defined binding partners, an unbiased SH3-proteome screen identified ADAM15 as a high-affinity SNX30 ligand, defining its first molecular interaction.

    Evidence Phage display of the complete human SH3 proteome with binding affinity measurement

    PMID:16374509

    Open questions at the time
    • No reciprocal validation or mutagenesis in the original report
    • Functional consequence of the ADAM15 interaction not addressed
    • No cellular context for the interaction
  2. 2009 Medium

    To test whether the ADAM15 interaction occurs in cells and how it is regulated, co-precipitation across ADAM15 splice isoforms showed binding requires the most C-terminal proline cluster, establishing alternative splicing as the regulatory switch for the SNX30–ADAM15 association.

    Evidence Co-precipitation from cell lysates with isoform-specific constructs and proline-cluster mutagenesis

    PMID:19718658

    Open questions at the time
    • Biological output of the SNX30–ADAM15 complex not defined
    • Single lab without independent confirmation
    • Subcellular site of the interaction not mapped
  3. 2020 High

    To place SNX30 within sorting nexin membrane assemblies, reciprocal co-IP, CRISPR deletion, and imaging demonstrated SNX30 forms SNX4 heterodimers on tubulovesicular endocytic membranes but, unlike SNX4–SNX7, is dispensable for autophagy and ATG9A trafficking, defining the specificity of SNX4-based complexes.

    Evidence siRNA, CRISPR-Cas9 deletion, reciprocal co-immunoprecipitation, fluorescence imaging, and autophagosome assays

    PMID:32513819

    Open questions at the time
    • The cargo trafficked by the SNX4–SNX30 heterodimer is not identified
    • Physiological pathway served by SNX4–SNX30 not defined
    • Relationship to the ADAM15 interaction not explored
  4. 2025 Medium

    To assign a disease-relevant cellular function, SNX30 overexpression in lung adenocarcinoma cells was shown to suppress proliferation and induce ferroptosis by negatively regulating SETDB1, with SETDB1 rescue reversing the phenotype, placing SNX30 upstream of SETDB1 in a ferroptosis pathway.

    Evidence Plasmid overexpression, proliferation and ROS/iron assays, RT-qPCR, western blot, and SETDB1 rescue with ferrostatin-1 control

    PMID:39780196

    Open questions at the time
    • Mechanism linking SNX30 to SETDB1 regulation is unknown
    • Overexpression-based, single lab and single study
    • Connection to SNX30's membrane-trafficking activity not established

Open questions

Synthesis pass · forward-looking unresolved questions
  • How SNX30's endocytic membrane-trafficking activity mechanistically connects to its ADAM15 interaction and its SETDB1-dependent tumor-suppressive role remains unresolved.
  • No structural model of SNX30 or its complexes
  • No identified cargo for the SNX4–SNX30 heterodimer
  • Molecular mechanism of SETDB1 regulation undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 3
Localization
GO:0031410 cytoplasmic vesicle 1
Partners
Complex memberships
SNX4-SNX30 heterodimer

Evidence

Reading pass · 4 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2006 SNX30 (identified as an ADAM15-binding sorting nexin family member) was discovered as a novel SH3-domain-containing protein that binds ADAM15 via phage display of the complete human SH3 proteome, with nanomolar affinity. Phage display of human SH3 proteome; binding affinity assay EMBO reports Medium 16374509
2009 SNX30 (referred to as SNX33 a.k.a. SNX30 in this paper) co-precipitates with specific ADAM15 isoforms from cell lysates; robust cellular association with SNX30 was observed only for ADAM15 isoforms containing the most carboxyterminal proline cluster, establishing that alternative mRNA splicing of ADAM15 regulates its interaction with SNX30. Co-precipitation from cell lysates; isoform-specific expression constructs; mutagenesis of proline-rich regions Journal of cellular biochemistry Medium 19718658
2020 SNX30 forms functional heterodimers with SNX4 that associate with tubulovesicular endocytic membranes, as shown by co-immunoprecipitation and imaging; however, the SNX4-SNX7 heterodimer (not SNX4-SNX30) was specifically required for autophagy and ATG9A trafficking, indicating SNX4-SNX30 is not the autophagy-specific complex. siRNA knockdown, CRISPR-Cas9 deletion, co-immunoprecipitation, fluorescence imaging, autophagosome assembly assays Journal of cell science High 32513819
2025 SNX30 overexpression in lung adenocarcinoma cell lines inhibits cell proliferation, induces ferroptosis (increased ROS, intracellular iron, Ptgs2, Chac1; decreased Cys, GSH, GPX4), and negatively regulates SETDB1 expression; rescue of SETDB1 reversed SNX30-induced ferroptosis, placing SNX30 upstream of SETDB1 in a ferroptosis pathway. Plasmid overexpression, CCK8 proliferation assay, flow cytometry (apoptosis/ROS), iron assay kits, RT-qPCR, western blotting, ferrostatin-1 rescue experiment Journal of cardiothoracic surgery Medium 39780196

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome. EMBO reports 99 16374509
2022 Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease. Diabetologia 50 35763030
2020 A heterodimeric SNX4--SNX7 SNX-BAR autophagy complex coordinates ATG9A trafficking for efficient autophagosome assembly. Journal of cell science 37 32513819
2021 Epigenome-wide analysis of DNA methylation and coronary heart disease: a nested case-control study. eLife 24 34515027
2009 Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins. Journal of cellular biochemistry 18 19718658
2019 Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma. Journal of computational biology : a journal of computational molecular cell biology 17 31750732
2025 Transcriptomic Signatures in TP53 Positive and Negative Tumor Samples in NSCLC. Current gene therapy 6 40798960
2026 Integrated miRNA-proteomic profiling identifies chronic vesicle-trafficking and proteostasis disruptions after mild traumatic brain injury. Experimental neurology 0 41605412
2026 Integrative eQTL and Mendelian Randomization Analyses with Experimental Validation Prioritize Genetic Candidate Biomarkers for Crohn's Disease. Endocrine, metabolic & immune disorders drug targets 0 42059218
2025 SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1. Journal of cardiothoracic surgery 0 39780196
2025 Anthraquinone-2-Carboxylic Acid Is a Potential Antiviral Candidate Against Influenza Viruses In Vitro and In Vivo. Viruses 0 40431640
2025 Susceptibility and protective genes in diabetic retinopathy: A comprehensive single-cell RNA sequencing analysis. Experimental eye research 0 41076048

Missed literature

Know a paper Affinage missed for SNX30? Flag it for the maintainers and the community.

No submissions yet.